Fig. 2From: A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses (ILIFE) trialSPIRIT figure: time schedule of enrollment, interventions, and assessments. An asterisk denotes blood count, biochemistry, autoimmune profile, and coagulation profileBack to article page